4.0
15. Nov. 2022
Ehemaliger Mitarbeiter, mehr als 1 Jahr
San Diego, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Dexcom is the industry leader and primary patent owner for Continuous Glucose Monitoring (CGM) apparatuses and is well poised for continued growth which means both job security and good prospects for stock price increases over time.
Kontras
No shortage of work, especially within the Finance Org, which leads to little to no downtime and burnout.